The SAM pharmaceutical isolator market is expected to grow from US$ 373.13 million in 2021 to US$ 634.67 million by 2028; it is estimated to grow at a CAGR of 7.9% from 2021 to 2028.
Brazil and Argentina are major economies in SAM. Increase in investments by pharmaceutical and biotechnology industry is expected to surge the market growth. Several big and small pharmaceutical companies are engaged in the development and manufacturing of new and novel molecules for life-threatening conditions. Pharmaceutical isolator systems have been regarded as a key technology in the drug discovery process. Thus, the adoption of pharmaceutical isolators is increasing to ensure contamination-free manufacturing and product handling. The pharmaceutical isolator provides safety to an operator from the exposure of harmful drugs, eliminates the possibilities of cross-contamination, and maintains the standard of drug quality. In the pharmaceutical industry, it is extremely important to maintain immense caution during the product manufacturing process. Different types of isolators are available in the pharmaceutical market that provide an optimum level of sterility in the product manufacturing process. The handling of pharmaceuticals with high potency ingredients, such as hormones and antibiotics. Biologic drugs need a greater level of precautions. Pharma and biotech companies have substantially invested in pharmaceutical isolator techniques in the past decade. Growing investments by pharmaceutical and biotechnology companies and extensive drug pipelines for the treatment of various chronic diseases, such as cancer, cardiovascular disorders, metabolic disorders, immunological disorders, and neurological disorders, are the prominent drivers for the growth of the SAM pharmaceutical isolator market.
In case of COVID-19, SAM is highly affected especially Brazil. The COVID-19 is expected to result in the region's worst recession, causing a 9.1% contraction in regional GDP in 2020. This is expected to increase the number of poor up by 45 million and the extremely poor number by 28 million. The increasing incidence of COVID 19 supports the growth of the market. International market players are entering the region and offering various aseptic systems required by the pharmaceutical industry. For instance, in November 2020, Optima Pharma has conducted seminar in Brazil regarding use of Isolator and RABS Solutions during pandemic. Such an initiatives will support the market growth in the region. Also, the pharmaceutical & biotechnology invested in R&D for the new molecule entity. The pandemic as no impact on R&D process, due to pandemic R&D activity increase to find better medicines to cure the life-threatening disease. These factors had a high impact on the SAM pharmaceutical isolator market. According to the Brazilian Association of Generic Medicines Industries (PróGenlicos), 75% of the pharmaceutical product is done domestically. However, it is widely dependent on the imports of APIs. The rise in the demand for aseptic processing has created several opportunities for the manufacturers in the country. Similarly, it is a vital challenge in other countries such as Brazil, and Argentina. Therefore, the government is collaborating with the private market player to supply vaccines against COVID–19. Such factors are also expected to create opportunities for countries. It is further expected to show a positive impact on market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM pharmaceutical isolator market. The SAM pharmaceutical isolator market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
SAM Pharmaceutical Isolator Market Segmentation
SAM Pharmaceutical Isolator Market – By Type
- Open Isolators
- Closed Isolators
SAM Pharmaceutical Isolator Market – By Pressure
- Positive Pressure
- Negative Pressure
SAM Pharmaceutical Isolator Market – By Configuration
- Floor Standing
- Modular
- Compact
- Mobile
SAM Pharmaceutical Isolator Market – By Application
- Aseptic
- Sampling & Weighing
- Fluid Dispensing
- Containment
- Others
SAM Pharmaceutical Isolator Market – By End User
- Pharmaceutical and Biotechnology Companies
- Hospitals
- Research and Academic Laboratories
- Other
SAM Pharmaceutical Isolator Market, by Country
- Brazil
- Argentina
- Rest of SAM
SAM Pharmaceutical Isolator Market -Companies Mentioned
- Azbil Telstar
- Bioquell (Ecolab Solution)
- Comecer
- Fedegari Autoclavi S.p.A.
- Getinge AB
- Hosokawa Micron Group
- Nuaire Inc.
South America Pharmaceutical Isolator Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 373.13 Million |
Market Size by 2028 | US$ 634.67 Million |
Global CAGR (2021 - 2028) | 7.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | South and Central America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- Azbil Telstar
- Bioquell (Ecolab Solution)
- Comecer
- Fedegari Autoclavi S.p.A.
- Getinge AB
- Hosokawa Micron Group
- Nuaire Inc.


